Answers are grounded in this paper and cite their sources.
Background: Acute myeloid leukaemia (AML) is a common and aggressive haematological neoplasm. Limited studies of AML in South Africa have shown differences in age at diagnosis and overall survival (OS) compared to international studies. Aim: To determine the demographics, subtype and OS of AML. Setting: The study was conducted at the National Health Laboratory Service at Tygerberg Hospital, Cape Town, South Africa. Methods: Patients with newly diagnosed AML from 2015 to 2018 were identified. The diagnostic subtype and prognostic group for each AML was determined. Survival analysis was performed. Results: Ninety patients were included. The median age of adults was 54 years (interquartile range [IQR] 38 years – 65 years, n = 77), and for children was 2 years (IQR 2 years – 7 years, n = 13). The male-to-female ratio was 1:1.4. Acute promyelocytic leukaemia (21%) and AML myelodysplasia related (19%) were the commonest subtypes. The 3-year OS in children, adults < 60 years and adults ≥ 60 years was 46%, 21% and 3%, respectively. Adverse risk group increased risk of death (p = 0.003, n = 38). Age, white cell count and platelet count were independent risk factors for death. Conclusion: In contrast to high-income countries, our findings show a younger age at AML diagnosis, a female predominance and a lower OS. Age and full blood count (FBC) parameters are important predictors for OS. Contribution: The findings complement other studies published in South Africa, showing younger age at diagnosis and inferior OS of AML, while highlighting the importance of FBC findings.
No takes yet. Share an insight, caveat, or question.
Moodley et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: